Highlights: U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS Clears the way for entry into the HEALEY ALS ...
Washingtonian on MSN
Breaking Barriers in Care: New Clinical Services Designed for Adults with Disabilities
For too long, people with intellectual and developmental disabilities (IDD) have had to navigate a healthcare system that wasn’t built for them. Rushed appointments, providers who aren’t trained in ...
Neurizon Therapeutics (ASX:NUZ) has opened Monday up +7% after the U.S. Food and Drug Administration lifted the clinical hold ...
The Orangery Tea Room at Ketteringham Hall has announced a new afternoon tea inspired by the Little Lifts charity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback